consistent with the adult indications of the originator biologic Stelara ® ** Logo de Fresenius Kabi (CNW Group/Fresenius Kabi Canada Inc.) "The launch of Otulfi™ is an important milestone on ...

TORONTO, May 27, 2025 /CNW/ - Fresenius Kabi Canada announces that its ustekinumab biosimilar, developed by Formycon AG, is now commercially available in Canada. Otulfi ™ is indicated for the ...

The Trinity logo should always appear in the top left-hand corner of documents, and should not be centred. The shield should be used together with the text as a full logo and the shield should never ...

The Prices page of Fresenius Kabi Oncology Ltd.. captures the information on Price and Volume for a user defined time interval. It also contains the Live Stock Price and Volume, 52 Week High Low, Bid ...

With this launch, Fresenius Kabi Canada's immunology biosimilar portfolio is further expanding, offering more treatment options for patients with chronic autoimmune conditions Tyenne ® is Fresenius ...

Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States in 30 mg per 30 mL multi-dose vials. Epinephrine Injection ...

Fresenius Kabi, an operating company of Fresenius, announced today that Epinephrine Injection, USP, is now available in the United States in 30 mg per 30 mL multi-dose vials.

LAKE ZURICH, Ill. - Fresenius Kabi, a health care company and part of the Fresenius Group, with a market capitalization of $447 million and a "FAIR" overall financial health rating according to ...

Much of the internet has been left completely baffled over the weekend after a ‘transparent phone’ started doing the rounds. The bizarre bit of ‘tech’ ended up going viral because ...

The FDA designated Fresenius Kabi's Otulfi® (ustekinumab-aauz) as an interchangeable biosimilar to the reference product Stelara® (ustekinumab). The FDA designated Fresenius Kabi's Otulfi ...

Planegg-Martinsried, Germany – Formycon AG (FSE: FYB, Prime Standard, “Formycon”) and its commercialization partner Fresenius Kabi announce today that the U.S. Food and Drug Administration (FDA) ...